Additional file 1 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

Additional file 1. Supplementary Tables 1-4 and 7-15. Table S1. 50 immunomodulators. Table S2. Effector genes of TIICs. Table S3. Gene sets of therapeutic signatures. Table S4. Gene sets of cell death signatures. Table S7. Co-Expressed genes of NAPSB. Table S8. Upregulated expressed genes between NAPSB subgroups. Table S9. Common genes of co-expressed genes and upregulated DEGs. Table S10. Functional annotation and pathway analysis for common genes (Gene Ontology-Biological process). Table S11. Functional annotation and pathway analysis for common genes (KEGG pathways).

附加文件1：补充表1~4及表7~15。表S1：50种免疫调节剂（immunomodulators）。表S2：肿瘤浸润免疫细胞（Tumor-Infiltrating Immune Cells，TIICs）效应基因。表S3：治疗特征基因集。表S4：细胞死亡特征基因集。表S7：NAPSB的共表达基因。表S8：NAPSB亚组间的上调表达基因。表S9：共表达基因与上调差异表达基因（differentially expressed genes，DEGs）的共有基因。表S10：针对共有基因的功能注释与通路分析（基因本体-生物学过程，Gene Ontology-Biological Process）。表S11：针对共有基因的功能注释与通路分析（KEGG通路）。